What one share of Standard BioTools holds
At Standard BioTools, Inc. ("Standard BioTools" or the "Company"), we are committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world class management team.
Standard BioTools’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.22 |
|---|---|
| Profit | $0.22 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.21 |
| Cash and investments | $0.69 |
| Book value | $1.38 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $14.64 | −$11.02 | $0.46 | −$11.70 | — | −$100.03 |
| 2010 | $17.76 | −$8.94 | $0.81 | −$6.90 | — | −$97.66 |
| 2011 | $2.40 | −$1.81 | $0.09 | −$1.08 | — | $2.80 |
| 2012 | $2.36 | −$0.86 | $0.11 | −$0.90 | — | $4.01 |
| 2013 | $2.79 | −$0.65 | $0.14 | −$0.20 | — | $3.74 |
| 2014 | $4.19 | −$1.90 | $0.27 | −$1.08 | — | $5.31 |
| 2015 | $4.00 | −$1.86 | $0.14 | −$1.35 | — | $3.98 |
| 2016 | $3.60 | −$2.62 | $0.17 | −$1.52 | — | $1.82 |
| 2017 | $3.09 | −$1.84 | $0.05 | −$0.78 | — | $0.80 |
| 2018 | $2.85 | −$1.49 | $0.01 | −$0.64 | — | $1.46 |
| 2019 | $1.76 | −$0.97 | $0.04 | −$0.57 | — | $2.20 |
| 2020 | $1.92 | −$0.74 | $0.18 | −$0.39 | — | $1.87 |
| 2021 | $1.72 | −$0.78 | $0.17 | −$0.76 | — | $1.23 |
| 2022 | $1.25 | −$2.43 | $0.05 | −$1.19 | — | −$1.02 |
| 2023 | $1.34 | −$0.94 | $0.04 | −$0.58 | — | −$1.85 |
| 2024 | $0.26 | −$0.52 | $0.02 | −$0.43 | — | $1.25 |
| 2025 | $0.22 | −$0.20 | $0.02 | −$0.22 | — | $1.10 |
Common questions about Standard BioTools
How much does one share of Standard BioTools earn?
Over the last 12 months, each share of Standard BioTools earned $0.22 of profit on $0.22 of sales, keeping about 100¢ of every $1 (profit margin).
Does Standard BioTools pay a dividend?
Standard BioTools didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Standard BioTools’s book value per share?
Standard BioTools’s book value is $1.38 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Standard BioTools have?
Each share of Standard BioTools has $0.69 of cash and investments, as of June 30, 2026.
What is Standard BioTools’s free cash flow per share?
−$0.21 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Standard BioTools bought back shares?
Standard BioTools’s share count rose about 21886% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.